LXEH:NASDAQLixiang Education Holding Co., Ltd. Analysis
Data as of 2026-04-16 - not real-time
$0.18
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Technical outlook is clearly bearish: the 20‑day SMA (≈0.203) sits below the 50‑day SMA (≈0.223) and far beneath the 200‑day SMA (≈0.859), the price of $0.18 is hugging the identified support at $0.16 and well under the resistance near $0.255, RSI is modest at 43, and the MACD histogram is negative, confirming a bearish momentum. Volume is increasing but the price remains constrained, suggesting accumulation without upward price pressure.
Fundamentals are in distress: the company reports deeply negative gross (‑25%) and operating margins (‑98%), zero operating cash flow, a staggering max drawdown of over 99%, and a debt‑to‑equity ratio near 50, while trading at a price‑to‑book of 0.09 and price‑to‑sales of 0.105. The Chinese private‑education sector faces heightened regulatory scrutiny, adding further headwinds, and the market’s “Extreme Greed” sentiment appears disconnected from the underlying financial reality.
Fundamentals are in distress: the company reports deeply negative gross (‑25%) and operating margins (‑98%), zero operating cash flow, a staggering max drawdown of over 99%, and a debt‑to‑equity ratio near 50, while trading at a price‑to‑book of 0.09 and price‑to‑sales of 0.105. The Chinese private‑education sector faces heightened regulatory scrutiny, adding further headwinds, and the market’s “Extreme Greed” sentiment appears disconnected from the underlying financial reality.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 9/10
Key Factors
- Bearish technical indicators (price below SMA20/50, negative MACD)
- Proximity to support level with limited upside
- Severe negative profitability and cash flow
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Extremely low valuation multiples (PB 0.09, P/S 0.105)
- Potential restructuring or capital infusion
- Continued regulatory and operational uncertainty in Chinese education
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Deep discount to book value offering speculative upside
- Possibility of a turnaround if regulatory environment eases
- Persistently high debt load and negative earnings limiting confidence
Key Metrics & Analysis
Financial Health
Revenue Growth0.30%
Profit Margin-97.79%
ROE-14.83%
ROA-4.40%
Debt/Equity49.08
P/B Ratio0.1
Technical Analysis
TrendBearish
RSI43.1
Support$0.16
Resistance$0.25
MA 20$0.20
MA 50$0.22
MA 200$0.86
MACDBearish
VolumeIncreasing
Fear & Greed Index88.98
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta-0.19
Volatility184.40%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.